Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Subcutaneous Morphine Administration in Palliative Care

  • The British Medical Journal recommends that subcutaneous morphine may be given either as bolus injections every four hours or by continuous infusion for palliative care patients 1, 2
  • The rescue dose for breakthrough pain should be the same as the regular four-hourly dose and may be given as often as required (e.g., every hour) 3, 4
  • The total daily dose of morphine should be adjusted daily according to how many rescue doses have been needed in the previous 24 hours 3, 5
  • If pain returns consistently before the next regular dose is due, the regular dose should be increased 6, 2

Dosing Considerations

  • The relative potency ratio of oral morphine to subcutaneous morphine is approximately 1:2, meaning subcutaneous doses should be half the oral dose 2
  • For patients receiving regular subcutaneous morphine every four hours, a double dose at bedtime is recommended to avoid being woken by pain 2
  • Subcutaneous morphine is preferred over intramuscular administration for chronic cancer pain as it is simpler and less painful 6

Contraindications and Special Considerations

  • Subcutaneous administration of morphine may not be practical in patients with generalized edema, soreness, or sterile abscesses, erythema at injection sites, coagulation disorders, or very poor peripheral circulation [2, @16@]

Implementation in Practice

  • For patients unable to take oral medications, subcutaneous administration is one of the preferred alternative routes 2, 7
  • Expert guidelines indicate that this approach produces effective control of chronic cancer pain in approximately 80% of patients [2, @18@]